Add Company
Join Now

AusperBio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AusperBio's estimated annual revenue is currently $1.1M per year.(i)
  • AusperBio's estimated revenue per employee is $155,000

Employee Data

  • AusperBio has 7 Employees.(i)
  • AusperBio grew their employee count by 75% last year.

AusperBio's People

NameTitleEmail/Phone
1
Co-Founder & CEOReveal Email/Phone
2
Co-Founder & CEOReveal Email/Phone
3
Co-Founder & CSOReveal Email/Phone
4
SVP, ResearchReveal Email/Phone
5
VP, Clinical DevelopmentReveal Email/Phone
6
Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is AusperBio?

AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus on curing chronic hepatitis B. The company has developed a proprietary Med-OligoTM ASO platform with novel insights into ASO design and capabilities to substantially enhance the current ASO therapeutics. Combining with efficient targeted delivery conjugation technologies, the modular Med-OligosTM Platform empowers ASO therapeutics to treat broad viral infections, metabolic conditions, genetic disorders, and immune diseases.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

75%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.5M70%N/A
#2
$0.1M7-36%$18.6M
#3
$0.5M7133%N/A
#4
$1M7600%N/A
#5
$0.1M7-12%$32.5M